Search
for
Sort by
Research 781–810 of 1000+
- Skin Cell Heterogeneity in Development, Wound Healing, and Cancer
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Regulatory T cells in skin
- Ultraviolet Radiation in Wound Care: Sterilization and Stimulation
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.
- Profile of dermatological consultations in Brazil (2018)
- Oxidative stress management in the hair follicle: Could targeting NRF2 counter age‐related hair disorders and beyond?
- Polycystic ovary syndrome: A review for dermatologists
- Dormancy in the stem cell niche
- Gender-Affirming Hormone Therapy for Transgender Men
- New oral anticoagulants and their reversal agents
- Dermatologie care behind bars
- Antiandrogen Therapy for Skin and Hair Disease
- Identifying the supportive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review
- 12-Chloracetyl-PPD, a novel dammarane derivative, shows anti-cancer activity via delay the progression of cell cycle G2/M phase and reactive oxygen species-mediate cell apoptosis
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Cellular heterogeneity and microenvironmental control of skin cancer
- Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Patient Preferences: Results of a German Adaptive Choice-Based Conjoint Analysis (Market Research Study Sponsored by Eli Lilly and Company) in Patients on Palliative Treatment for Advanced Breast Cancer
- Chemical pharmacotherapy options for managing adult acne
- The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review